153 related articles for article (PubMed ID: 28870807)
1. A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling.
Pei Z; Fu W; Wang G
Biochem Biophys Res Commun; 2017 Nov; 493(1):455-460. PubMed ID: 28870807
[TBL] [Abstract][Full Text] [Related]
2. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
3. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
[TBL] [Abstract][Full Text] [Related]
4. Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway.
Wang G; Huang YX; Zhang R; Hou LD; Liu H; Chen XY; Zhu JS; Zhang J
Int J Oncol; 2017 Nov; 51(5):1563-1573. PubMed ID: 29048657
[TBL] [Abstract][Full Text] [Related]
5. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
[TBL] [Abstract][Full Text] [Related]
6. Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway.
Wang G; Feng CC; Chu SJ; Zhang R; Lu YM; Zhu JS; Zhang J
Int J Oncol; 2015 Nov; 47(5):1767-74. PubMed ID: 26398368
[TBL] [Abstract][Full Text] [Related]
7. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
[TBL] [Abstract][Full Text] [Related]
8. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
Jeon MJ; Kim WG; Lim S; Choi HJ; Sim S; Kim TY; Shong YK; Kim WB
Mol Cell Endocrinol; 2016 Jan; 419():113-23. PubMed ID: 26463583
[TBL] [Abstract][Full Text] [Related]
9. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
10. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway.
Xu Q; Ma J; Lei J; Duan W; Sheng L; Chen X; Hu A; Wang Z; Wu Z; Wu E; Ma Q; Li X
Biomed Res Int; 2014; 2014():546353. PubMed ID: 24812621
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y
Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
[TBL] [Abstract][Full Text] [Related]
13. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
Cheng K; Hao M
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
[TBL] [Abstract][Full Text] [Related]
14. LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway.
Li J; Huang W; Han Q; Xiong J; Song Z
Med Oncol; 2021 Jan; 38(1):2. PubMed ID: 33392788
[TBL] [Abstract][Full Text] [Related]
15. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model.
Tang FY; Pai MH; Chiang EP
J Nutr Biochem; 2012 Oct; 23(10):1302-13. PubMed ID: 22221675
[TBL] [Abstract][Full Text] [Related]
16. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF
Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601
[TBL] [Abstract][Full Text] [Related]
17. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
[TBL] [Abstract][Full Text] [Related]
18. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
[TBL] [Abstract][Full Text] [Related]
19. Dehydroeffusol inhibits viability and epithelial-mesenchymal transition through the Hedgehog and Akt/mTOR signaling pathways in neuroblastoma cells.
He K; Duan G; Li Y
Eur J Pharmacol; 2018 Jun; 829():93-101. PubMed ID: 29665365
[TBL] [Abstract][Full Text] [Related]
20. Sedum sarmentosum Bunge extract induces apoptosis and inhibits proliferation in pancreatic cancer cells via the hedgehog signaling pathway.
Bai Y; Chen B; Hong W; Liang Y; Zhou M; Zhou L
Oncol Rep; 2016 May; 35(5):2775-84. PubMed ID: 26987050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
